2-piperidone has been researched along with Pulmonary Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Chen, Z; Cheng, S; Hu, S; Li, H; Ouyang, M; Peng, H; Xue, J; Yu, S; Zeng, W; Zhang, Y; Zhou, L | 1 |
| Bognár, B; Citro, LA; Hideg, K; Kálai, T; Khan, M; Kuppusamy, P; Meduru, S; Naidu, SK; Ravi, Y; Sai-Sudhakar, CB; Selvendiran, K | 1 |
2 other study(ies) available for 2-piperidone and Pulmonary Hypertension
| Article | Year |
|---|---|
The therapeutic effect and mechanism of Rapamycin combined with HO-3867 on monocrotaline-induced pulmonary hypertension in rats.
Topics: Animals; Disease Models, Animal; Hypertension, Pulmonary; Monocrotaline; Piperidones; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Sirolimus | 2022 |
Pulmonary hypertension secondary to left-heart failure involves peroxynitrite-induced downregulation of PTEN in the lung.
Topics: Animals; Cell Line; Down-Regulation; Heart Failure; Humans; Hypertension, Pulmonary; Lung; Male; Microvessels; Muscle, Smooth, Vascular; Oxidative Stress; Peroxynitrous Acid; Piperidones; PTEN Phosphohydrolase; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Ultrasonography | 2013 |